A quantitative magnetic resonance cholangiopancreatography metric of intrahepatic biliary dilatation severity detects high-risk primary sclerosing cholangitis
Magnetic resonance imaging with magnetic resonance cholangiopancreatography (MRI-MRCP) in primary sclerosing cholangitis (PSC) is currently based on qualitative assessment and has high interobserver variability. We investigated the utility and performance of quantitative metrics derived from a three...
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
Wiley
2021
|
| _version_ | 1797107766308896768 |
|---|---|
| author | Selvaraj, EA Ba-Ssalamah, A Poetter-Lang, S Ridgway, GR Brady, JM Collier, J Culver, EL Bailey, A Pavlides, M |
| author_facet | Selvaraj, EA Ba-Ssalamah, A Poetter-Lang, S Ridgway, GR Brady, JM Collier, J Culver, EL Bailey, A Pavlides, M |
| author_sort | Selvaraj, EA |
| collection | OXFORD |
| description | Magnetic resonance imaging with magnetic resonance cholangiopancreatography (MRI-MRCP) in primary sclerosing cholangitis (PSC) is currently based on qualitative assessment and has high interobserver variability. We investigated the utility and performance of quantitative metrics derived from a three-dimensional biliary analysis tool in adult patients with PSC. MRI-MRCP, blood-based biomarkers, and FibroScan were prospectively performed in 80 participants with large-duct PSC and 20 healthy participants. Quantitative analysis was performed using MRCP+ (Perspectum Ltd., United Kingdom), and qualitative reads were performed by radiologists. Inter-reader agreements were compared. Patients were classified into high risk or low risk for disease progression, using Mayo risk score (MRS), Amsterdam-Oxford model (AOM), upper limit of normal (ULN) alkaline phosphatase (ALP), disease distribution, and presence of dominant stricture. Performance of noninvasive tools was assessed using binomial logistic regressions and receiver operating characteristic curve analyses. Quantitative biliary metrics performed well to distinguish abnormal from normal bile ducts (P < 0.0001). Interobserver agreements for MRCP+ dilatation metrics (intraclass correlation coefficient, 0.90-0.96) were superior to modified Amsterdam intrahepatic stricture severity score (κ = 0.74) and Anali score (κ = 0.38). MRCP+ intrahepatic dilatation severity showed excellent performance to classify patients into high-risk and low-risk groups, using predictors of disease severity as the reference (MRS, P < 0.0001; AOM, P = 0.0017; 2.2 × ULN ALP, P = 0.0007; 1.5 × ULN ALP, P = 0.0225; extrahepatic disease, P = 0.0331; dominant stricture, P = 0.0019). MRCP+ intrahepatic dilatation severity was an independent predictor of MRS >0 (odds ratio, 31.3; P = 0.035) in the multivariate analysis. Conclusion: Intrahepatic biliary dilatation severity calculated using MRCP+ is elevated in patients with high-risk PSC and may be used as an adjunct for risk stratification in PSC. This exploratory study has provided the groundwork for examining the utility of novel quantitative biliary metrics in multicenter studies. |
| first_indexed | 2024-03-07T07:20:33Z |
| format | Journal article |
| id | oxford-uuid:e6388a4a-0186-4915-b183-0ce9b0ba2a60 |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-07T07:20:33Z |
| publishDate | 2021 |
| publisher | Wiley |
| record_format | dspace |
| spelling | oxford-uuid:e6388a4a-0186-4915-b183-0ce9b0ba2a602022-09-20T14:57:02ZA quantitative magnetic resonance cholangiopancreatography metric of intrahepatic biliary dilatation severity detects high-risk primary sclerosing cholangitisJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:e6388a4a-0186-4915-b183-0ce9b0ba2a60EnglishSymplectic ElementsWiley2021Selvaraj, EABa-Ssalamah, APoetter-Lang, SRidgway, GRBrady, JMCollier, JCulver, ELBailey, APavlides, MMagnetic resonance imaging with magnetic resonance cholangiopancreatography (MRI-MRCP) in primary sclerosing cholangitis (PSC) is currently based on qualitative assessment and has high interobserver variability. We investigated the utility and performance of quantitative metrics derived from a three-dimensional biliary analysis tool in adult patients with PSC. MRI-MRCP, blood-based biomarkers, and FibroScan were prospectively performed in 80 participants with large-duct PSC and 20 healthy participants. Quantitative analysis was performed using MRCP+ (Perspectum Ltd., United Kingdom), and qualitative reads were performed by radiologists. Inter-reader agreements were compared. Patients were classified into high risk or low risk for disease progression, using Mayo risk score (MRS), Amsterdam-Oxford model (AOM), upper limit of normal (ULN) alkaline phosphatase (ALP), disease distribution, and presence of dominant stricture. Performance of noninvasive tools was assessed using binomial logistic regressions and receiver operating characteristic curve analyses. Quantitative biliary metrics performed well to distinguish abnormal from normal bile ducts (P < 0.0001). Interobserver agreements for MRCP+ dilatation metrics (intraclass correlation coefficient, 0.90-0.96) were superior to modified Amsterdam intrahepatic stricture severity score (κ = 0.74) and Anali score (κ = 0.38). MRCP+ intrahepatic dilatation severity showed excellent performance to classify patients into high-risk and low-risk groups, using predictors of disease severity as the reference (MRS, P < 0.0001; AOM, P = 0.0017; 2.2 × ULN ALP, P = 0.0007; 1.5 × ULN ALP, P = 0.0225; extrahepatic disease, P = 0.0331; dominant stricture, P = 0.0019). MRCP+ intrahepatic dilatation severity was an independent predictor of MRS >0 (odds ratio, 31.3; P = 0.035) in the multivariate analysis. Conclusion: Intrahepatic biliary dilatation severity calculated using MRCP+ is elevated in patients with high-risk PSC and may be used as an adjunct for risk stratification in PSC. This exploratory study has provided the groundwork for examining the utility of novel quantitative biliary metrics in multicenter studies. |
| spellingShingle | Selvaraj, EA Ba-Ssalamah, A Poetter-Lang, S Ridgway, GR Brady, JM Collier, J Culver, EL Bailey, A Pavlides, M A quantitative magnetic resonance cholangiopancreatography metric of intrahepatic biliary dilatation severity detects high-risk primary sclerosing cholangitis |
| title | A quantitative magnetic resonance cholangiopancreatography metric of intrahepatic biliary dilatation severity detects high-risk primary sclerosing cholangitis |
| title_full | A quantitative magnetic resonance cholangiopancreatography metric of intrahepatic biliary dilatation severity detects high-risk primary sclerosing cholangitis |
| title_fullStr | A quantitative magnetic resonance cholangiopancreatography metric of intrahepatic biliary dilatation severity detects high-risk primary sclerosing cholangitis |
| title_full_unstemmed | A quantitative magnetic resonance cholangiopancreatography metric of intrahepatic biliary dilatation severity detects high-risk primary sclerosing cholangitis |
| title_short | A quantitative magnetic resonance cholangiopancreatography metric of intrahepatic biliary dilatation severity detects high-risk primary sclerosing cholangitis |
| title_sort | quantitative magnetic resonance cholangiopancreatography metric of intrahepatic biliary dilatation severity detects high risk primary sclerosing cholangitis |
| work_keys_str_mv | AT selvarajea aquantitativemagneticresonancecholangiopancreatographymetricofintrahepaticbiliarydilatationseveritydetectshighriskprimarysclerosingcholangitis AT bassalamaha aquantitativemagneticresonancecholangiopancreatographymetricofintrahepaticbiliarydilatationseveritydetectshighriskprimarysclerosingcholangitis AT poetterlangs aquantitativemagneticresonancecholangiopancreatographymetricofintrahepaticbiliarydilatationseveritydetectshighriskprimarysclerosingcholangitis AT ridgwaygr aquantitativemagneticresonancecholangiopancreatographymetricofintrahepaticbiliarydilatationseveritydetectshighriskprimarysclerosingcholangitis AT bradyjm aquantitativemagneticresonancecholangiopancreatographymetricofintrahepaticbiliarydilatationseveritydetectshighriskprimarysclerosingcholangitis AT collierj aquantitativemagneticresonancecholangiopancreatographymetricofintrahepaticbiliarydilatationseveritydetectshighriskprimarysclerosingcholangitis AT culverel aquantitativemagneticresonancecholangiopancreatographymetricofintrahepaticbiliarydilatationseveritydetectshighriskprimarysclerosingcholangitis AT baileya aquantitativemagneticresonancecholangiopancreatographymetricofintrahepaticbiliarydilatationseveritydetectshighriskprimarysclerosingcholangitis AT pavlidesm aquantitativemagneticresonancecholangiopancreatographymetricofintrahepaticbiliarydilatationseveritydetectshighriskprimarysclerosingcholangitis AT selvarajea quantitativemagneticresonancecholangiopancreatographymetricofintrahepaticbiliarydilatationseveritydetectshighriskprimarysclerosingcholangitis AT bassalamaha quantitativemagneticresonancecholangiopancreatographymetricofintrahepaticbiliarydilatationseveritydetectshighriskprimarysclerosingcholangitis AT poetterlangs quantitativemagneticresonancecholangiopancreatographymetricofintrahepaticbiliarydilatationseveritydetectshighriskprimarysclerosingcholangitis AT ridgwaygr quantitativemagneticresonancecholangiopancreatographymetricofintrahepaticbiliarydilatationseveritydetectshighriskprimarysclerosingcholangitis AT bradyjm quantitativemagneticresonancecholangiopancreatographymetricofintrahepaticbiliarydilatationseveritydetectshighriskprimarysclerosingcholangitis AT collierj quantitativemagneticresonancecholangiopancreatographymetricofintrahepaticbiliarydilatationseveritydetectshighriskprimarysclerosingcholangitis AT culverel quantitativemagneticresonancecholangiopancreatographymetricofintrahepaticbiliarydilatationseveritydetectshighriskprimarysclerosingcholangitis AT baileya quantitativemagneticresonancecholangiopancreatographymetricofintrahepaticbiliarydilatationseveritydetectshighriskprimarysclerosingcholangitis AT pavlidesm quantitativemagneticresonancecholangiopancreatographymetricofintrahepaticbiliarydilatationseveritydetectshighriskprimarysclerosingcholangitis |